70
Participants
Start Date
June 30, 2016
Primary Completion Date
October 31, 2017
Study Completion Date
October 31, 2017
Fosbretabulin tromethamine
CA4P is a synthetic phosphorylated prodrug of CA4, a naturally occurring derivative of the South African willow tree, combretum caffrum. CA4P targets pre-existing tumor vasculature, resulting in an acute, reversible reduction in TBF that leads to central necrosis within tumors.
Placebo
Saline for infusion
Memorial Sloan Kettering Cancer Center, New York
The Western Pennsylvania Hospital, Pittsburgh
Lehigh Valley Hospital, John and Dorothy Morgan Cancer Center; Affiliate Memorial Sloan Kettering, Allentown
Mercy Medical Center; The Institute for Cancer Care, Baltimore
Gibbs Cancer Center & Research Institute Spartanburg Medical Center, Spartanburg
Augusta University, Augusta
Sylvester Comprehensive Cancer Center University of Miami, Miami
Baptist Health Medical Group Oncology, LLC, Miami
Moffitt Cancer Center, Tampa
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Mitchell Cancer Institute - USA Health System, Mobile
Gabrail Cancer Center, Canton
Universitätsklinikum Essen (AöR) Klinik für Frauenheilkunde und Geburtshilfe, Essen
HCA Midwest Division - Sarah Cannon Cancer Institute, Kansas City
Universitäts-Frauenklinik Dept. für Frauengesundheit, Tübingen
Oklahoma Heath Sciences Center - Stephenson Cancer Center, Oklahoma City
Tulsa Cancer Institute, Tulsa
Dallas County Hospital District d/b/a Parkland Health and Hospital System, Dallas
Simmons Comprehensive Cancer Center; UT Southwestern Medical Center, Dallas
Texas Oncology, P.A., Dallas
Texas Oncology, P.A., Tyler
Texas Oncology, Bedford
Texas Oncology, P.A., The Woodlands
Texas Oncology San Antonio, San Antonio
Texas Oncology, P.A., Austin
Rocky Mountain Cancer Centers, LLP, Lakewood
Arizona Oncology Associates, PC - HAL, Phoenix
Arizona Oncology Associates, PC - HOPE, Tucson
University of Arizona Cancer Center, Tucson
Oncology Institute of Hope and Innovation, Lynwood
University of California Irvine, Orange
Sansum Clinic, Santa Barbara
California Pacific Medical Center, Research Institute, San Francisco
OHSU Center for Women's Health & Knight Cancer Institute, Portland
Willamette Valley Cancer Institute, Springfield
Hartford Health Care Cancer Institute; Affiliate Memorial Sloan Kettering, Hartford
Stamford Hospital - Bennett Cancer Center, Stamford
Maine Medical Center, Scarborough
UZ Leuven, Leuven
Universitätsklinikum Erlangen, Erlangen
Lead Sponsor
Mateon Therapeutics
INDUSTRY